EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimization of Intra-Arterial Administration of Chemotherapeutic Agents for Glioblastoma in the F98-Fischer Glioma-Bearing Rat Model

Juliette Latulippe iD, Laurent-Olivier Roy, Fernand Gobeil, David Fortin

Biomolecules · 2025

DOI: 10.3390/biom15030421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Juliette Latulippe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Antineoplastic Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the National Bank research chair for the treatment of brain tumours as well as by the Fondation Coeur en Tête, the Fondation du CHUS…, National Bank research chair for the treatment of brain tumors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is a difficult disease to treat for different reasons, with the blood–brain barrier (BBB) preventing therapeutic drugs from reaching the tumor being one major hurdle. The median overall survival is only 14.6 months after the standard first line of treatment. At relapse, there is no recognized standard second-line treatment. Our team uses intra-arterial (IA) chemotherapy as a means to bypass the BBB, hence achieving an overall median survival of 25 months. However, most patients eventually fail the treatment and progress. This is why we wish to expand our portfolio of options in terms of chemotherapy agents available for IA administration. In this study, we tested topotecan, cytarabine, and new formulations of carboplatin and paclitaxel by IA administration in the F98-Fischer glioma-bearing rat model as a screening tool for identifying potential candidate drugs. The topotecan IA group showed increased survival compared to the intravenous (IV) group (29.0 vs. 23.5), whereas the IV cytarabine group survived longer than the IA group (26.5 vs. 22.5). The new formulation of carboplatin showed a significant increase in survival compared to two previous studies with the conventional form (37.5 vs. 26.0 and 30.0). As for paclitaxel, it was too neurotoxic for IA administration. Topotecan and the new formulation of carboplatin demonstrated significant results, warranting their transition for consideration in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsAntineoplastic AgentsAnimalsRatsTopotecanCarboplatinRats, Inbred F344PaclitaxelCell Line, TumorDisease Models, AnimalBlood-Brain BarrierCytarabineMaleHumansInjections, Intra-Arterial

Stichwörter der Autor:innen

blood–brain barriercarboplatinchemotherapeutic agentscytarabineglioblastomapaclitaxeltopotecan

Substanzen

TopotecanCarboplatinAntineoplastic AgentsPaclitaxelCytarabine

Autor:innen und Institutionen

  • Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
  • Division of Neurosurgery, Department of Surgery, Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.

ORCID-Profile: Juliette Latulippe

Förderung

  • This work was supported by the National Bank research chair for the treatment of brain tumours as well as by the Fondation Coeur en Tête, the Fondation du CHUS…
  • National Bank research chair for the treatment of brain tumors

Zitieren

APA

Latulippe, J., Roy, L. O., Gobeil, F., & Fortin, D. (2025). Optimization of Intra-Arterial Administration of Chemotherapeutic Agents for Glioblastoma in the F98-Fischer Glioma-Bearing Rat Model. Biomolecules. https://doi.org/10.3390/biom15030421

Vancouver

Latulippe J, Roy LO, Gobeil F, Fortin D. Optimization of Intra-Arterial Administration of Chemotherapeutic Agents for Glioblastoma in the F98-Fischer Glioma-Bearing Rat Model. Biomolecules. 2025. doi:10.3390/biom15030421

BibTeX
@article{Latulippe2025,
  author = {Latulippe, Juliette and Roy, Laurent-Olivier and Gobeil, Fernand and Fortin, David},
  title = {Optimization of Intra-Arterial Administration of Chemotherapeutic Agents for Glioblastoma in the F98-Fischer Glioma-Bearing Rat Model},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15030421}
}
Kostenlos starten →